P/E ratio for CVS Health (CVS)
P/E ratio as of March 2023 (TTM): 23.7
According to CVS Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.653. At the end of 2021 the company had a P/E ratio of 17.2.
P/E ratio history for CVS Health from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 17.2 | 37.95% |
| 2020 | 12.5 | -14.61% |
| 2019 | 14.6 | -112.25% |
| 2018 | -119 | -1164.75% |
| 2017 | 11.2 | -29.96% |
| 2016 | 16.0 | -23.7% |
| 2015 | 20.9 | |
| 2013 | 18.9 | 20.22% |
| 2012 | 15.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Walgreens Boots Alliance WBA | -9.65 | -140.79% | 🇺🇸 USA |
 1-800-PetMeds
PETS | 35.3 | 49.06% | 🇺🇸 USA |
 Rite Aid
RAD | -0.1545 | -100.65% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.